Healthcare -
Biotechnology - NASDAQ - US
$ 4.58
-2.14 %
$ 212 M
Market Cap
-1.61
P/E
FDMT - TOTAL CURRENT LIABILITIES
Total Current Liabilities FDMT - 4D Molecular Therapeutics, Inc.
19 M
LAST VALUE
7.70%
2 YEAR CAGR
18.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR